PM Parker

1.6k citations

21 papers · 1.2k · h-index 12

Impact in

Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Transplantation top 5%

Papers in

Hematology 17
- Hematopoietic Stem Cell Transplantation 15
- Acute Myeloid Leukemia Research 7
- Chronic Myeloid Leukemia Treatments 6
- Multiple Myeloma Research and Treatments 3
Public Health, Environmental and Occupational Health 11
- Acute Lymphoblastic Leukemia research 11

Co-authors: GM Schmidt (10 shared papers)DS Snyder (10 shared papers)EP Smith (8 shared papers)MR O’Donnell (10 shared papers)AP Nademanee (8 shared papers)A. Molina (3 shared papers)DE Stepan (3 shared papers)Auayporn Nademanee (5 shared papers)
Journals: Blood (11 papers)Journal of Clinical Oncology (4 papers)Bone Marrow Transplantation (2 papers)Biology of Blood and Marrow Transplantation (2 papers)Leukemia (2 papers)
Partner nations: United States Germany

In The Last Decade

PM Parker

18 papers receiving 1.1k citations

Peers

Countries citing papers authored by PM Parker

Since Specialization

Citations

This map shows the geographic impact of PM Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PM Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PM Parker more than expected).

Fields of papers citing papers by PM Parker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by PM Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PM Parker. The network helps show where PM Parker may publish in the future.

Co-authors

The 25 scholars most cited alongside PM Parker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with PM Parker Line = papers co-authored together PM Parker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Donor leukocyte infusions in acute lymphocytic leukemia Bone Marrow Transplantation ·RH Collins, Steven C. Goldstein, Sergio Giralt, John E. Levine, David Porter, William R. Drobyski, John Barrett, Mark D. Johnson, Allan D. Kirk, Mary M. Horowitz, PM Parker	2000	178
2	Thalidomide as salvage therapy for chronic graft-versus-host disease Blood ·PM Parker, Nelson J. Chao, AP Nademanee, MR O’Donnell, GM Schmidt, DS Snyder, AS Stein, EP Smith, A. Molina, DE Stepan	1995	139
3	Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. Journal of Clinical Oncology ·Margaret O’Donnell, G. Schmidt, Bernard Tegtmeier, C Faucett, J. L. Fahey, James I. Ito, AP Nademanee, Joyce C. Niland, PM Parker, EP Smith	1994	131
4	High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors Blood ·Auayporn Nademanee, MR O’Donnell, DS Snyder, GM Schmidt, PM Parker, AS Stein, EP Smith, A. Molina, DE Stepan, George Somlo	1995	126
5	The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone Blood ·Auayporn Nademanee, GM Schmidt, PM Parker, AC Dagis, A Stein, DS Snyder, M O’Donnell, EP Smith, DE Stepan, A. Molina	1995	118
6	High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells. Journal of Clinical Oncology ·Auayporn Nademanee, Irena Sniecinski, GM Schmidt, Andrew Dagis, Margaret O’Donnell, DS Snyder, PM Parker, Anthony S. Stein, EP Smith, A Molina	1994	105
7	Bone marrow transplantation for patients with Philadelphia chromosome- positive acute lymphoblastic leukemia Blood ·SJ Forman, MR O’Donnell, AP Nademanee, DS Snyder, PJ Bierman, GM Schmidt, JL Fahey, AS Stein, PM Parker, KG Blume	1987	94
8	Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission Blood ·NJ Chao, SJ Forman, GM Schmidt, DS Snyder, MD Amylon, PN Konrad, AP Nademanee, MR O’Donnell, PM Parker, AS Stein	1991	94
9	Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission Leukemia ·DS Snyder, AP Nademanee, MR O’Donnell, PM Parker, AS Stein, Kim Margolin, George Somlo, A Molina, Ricardo Spielberger, A. Kashyap, Henry C. Fung, ML Slovak, Andrew Dagis, RS Negrin, MD Amylon, KG Blume, SJ Forman	1999	81
10	Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease. Journal of Clinical Oncology ·N J Chao, A P Nademanee, GD Long, GM Schmidt, Timothy A. Donlon, PM Parker, ML Slovak, L S Nagasawa, KG Blume, Stephen J. Forman	1991	47
11	Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase Blood ·DS Snyder, RS Negrin, MR O’Donnell, NJ Chao, MD Amylon, GD Long, AP Nademanee, AS Stein, PM Parker, EP Smith	1994	31
12	High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission Leukemia ·AS Stein, MR O’Donnell, ML Slovak, AP Nademanee, Andrew Dagis, GM Schmidt, PM Parker, DS Snyder, EP Smith, George Somlo, Kim Margolin, Daniel A. Arber, Joyce C. Niland, SJ Forman	2000	14
13	Bone marrow transplantation for patients with Philadelphia chromosome- positive acute lymphoblastic leukemia Blood ·SJ Forman, MR O’Donnell, AP Nademanee, DS Snyder, PJ Bierman, GM Schmidt, JL Fahey, AS Stein, PM Parker, KG Blume	1987	6
14	Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission Blood ·NJ Chao, SJ Forman, GM Schmidt, DS Snyder, MD Amylon, PN Konrad, AP Nademanee, MR O’Donnell, PM Parker, AS Stein	1991	6
15	Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia Bone Marrow Transplantation ·Anthony S. Stein, Margaret O’Donnell, Timothy W. Synold, Andrew Dagis, A Tsirunyan, Auayporn Nademanee, PM Parker, Vinod Pullarkat, David S. Snyder, Ricardo Spielberger, Jeffry Wong, Joseph Alvarnas, Sandra H. Thomas, Stephen J. Forman	2010	3
16	Phase I trial of escalating doses of total marrow irradiation (TMI) with helical tomotherapy and peripheral blood progenitor cell rescue (PBPC) following high-dose melphalan and PBPC as part of tandem high-dose therapy (THDT) for patients with multiple myeloma (MM) Journal of Clinical Oncology ·Jeffrey Y.C. Wong, George Somlo, Ricardo Spielberger, Stephen J. Forman, Leslie Poppelwell, Timothy E. Schultheiss, Paul Frankel, A. Krishnan, Firoozeh Sahebi, PM Parker	2007	1
17	Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase Blood ·DS Snyder, RS Negrin, MR O’Donnell, NJ Chao, MD Amylon, GD Long, AP Nademanee, AS Stein, PM Parker, EP Smith	1994	1
18	The city of hope experience with novel transplant regimens that incorporate standard and escalated dose 90YTTRIUM ibritumomab tiuxetan (90Y-Zevalin®) radioimmunotherapy (RIT) for autologous stem cell transplantation (ASCT) in patients with B-cell non-Hodgkin’s lymphoma (NHL): targeted intensification without increased toxicity and elimination of total body irradiation (TBI) Biology of Blood and Marrow Transplantation ·Auayporn Nademanee, Henry C. Fung, A Molina, A. Krishnan, R. Rodriguez, Leslie Popplewell, Ricardo Spielberger, Maureen O’Donnell, D. Snyder, PM Parker, Anthony S. Stein, Neil Kogut, Peter Falk, Firoozeh Sahebi, Jasmine Zain, Wayne Saville, Andrew Raubitschek, Stephen J. Forman	2004	1
19	A Phase II Study of Sequential Velcade/Thalidomide/ Dexamethasone (VTD) as Maintenance Therapy Post Single Autologous Peripheral Stem Cell (PSCT) in Patients with Multiple Myeloma. Blood ·Firoozeh Sahebi, Amrita Krishnan, George Somlo, Leslie Popplewell, PM Parker, Ji‐Lian Cai, Len Farol, Ricardo Spielberger, Neil Kogut, Chatchada Karanes, Christopher Ruel, Paul Frankel, F Larios Arceo, Lupe Duarte, Margaret O’Donnell, Stephen J. Forman	2009	0
20	Outcomes for Unrelated Donor Hematopoietic Cell Transplantation (URD-HCT) for Patients with Acute Lymphoblastic Leukemia (ALL) Using Fractionated Total Body Irradiation (FTBI) and Etoposide (VP16). Blood ·Margaret O’Donnell, PM Parker, Andrew Dagis, ML Slovak, D. Snyder, Anthony S. Stein, Ricardo Spielberger, Anna Pawłowska, Joseph Rosenthal, Joycelynne Palmer, Neil Kogut, Stephen J. Forman	2008	0

About PM Parker

PM Parker is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (15 papers), Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (6 papers), Lymphoma Diagnosis and Treatment (3 papers), Multiple Myeloma Research and Treatments (3 papers), Cancer Treatment and Pharmacology (2 papers) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Hematology (765 citations), Transplantation (41 citations), Public Health, Environmental and Occupational Health (354 citations), Genetics (129 citations) and Oncology (319 citations). PM Parker has collaborated with scholars based in United States and Germany. Frequent co-authors include GM Schmidt, DS Snyder, EP Smith, MR O’Donnell, AP Nademanee, A. Molina, DE Stepan, Auayporn Nademanee, AS Stein and SJ Forman. Their work appears in journals such as Blood, Journal of Clinical Oncology, Bone Marrow Transplantation, Biology of Blood and Marrow Transplantation and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

PM Parker

Impact in

Papers in i

In The Last Decade

PM Parker

Peers

Countries citing papers authored by PM Parker

Fields of papers citing papers by PM Parker

All Works

About PM Parker

Explore authors with similar magnitude of impact

Papers in